share_log

Numinus Wellness Inc. Graduates to the OTCQX Best Market

Numinus Wellness Inc. Graduates to the OTCQX Best Market

努米納斯保健公司畢業於OTCQX最佳市場
PR Newswire ·  2022/01/26 17:26

VANCOUVER, BC, Jan. 26, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce that it will commence trading on the OTCQX® Best Market in the United States when the market opens tomorrow, Thursday, January 27, 2022. Numinus' shares previously traded on the Pink market and will continue to trade under the symbol "NUMIF."           

公元前温哥華,2022年1月26日/美通社/-努米納斯健康公司(“努米納斯”或“公司”)多倫多證券交易所股票代碼:NUMI)(OTCQX:NUMIF)是一家致力於創新治療和安全、循證的迷幻輔助治療的精神保健公司,該公司高興地宣佈將在OTCQX開始交易。®美國最好的市場明天開市時,2022年1月27日(星期四)。努米納斯的股票此前在Pink市場交易,並將繼續以“NUMIF”為代碼進行交易。

The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Trading on the OTCQX will provide greater visibility and accessibility of Numinus in the U.S.

OTCQX市場是為老牌的、以投資者為中心的美國和國際公司設計的。要獲得OTCQX的資格,公司必須達到較高的財務標準,遵循最佳的公司治理實踐,並證明符合適用的證券法。在OTCQX的交易將提高紐米納斯在美國的知名度和可及性。

"Graduating to the OTCQX is a first step towards further accessing U.S. based investors," stated Payton Nyquvest, Founder and CEO. "As we grow our network of Numinus Health wellness clinics to include locations in the U.S. – and build a stronger brand presence in this important market – we will also look to establish an even greater profile with the U.S. investment community."

創始人兼首席執行官佩頓·尼奎斯特説:“參加OTCQX是進一步接觸美國投資者的第一步。隨着我們擴大我們的努米納斯健康診所網絡,將其包括在美國的地點,並在這個重要的市場上建立更強大的品牌形象,我們還將尋求在美國投資界建立更大的形象。“

U.S. investors or other interested parties can find current financial disclosure and Real-Time Level 2 quotes for the company on .

美國投資者或其他感興趣的各方可以在上找到該公司的當前財務披露和實時二級報價。

About Numinus
Numinus Wellness (TSX: NUMI;OTCQX: NUMIF) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

關於努米諾斯
紐米納斯健康公司(多倫多證券交易所股票代碼:NUMI;多倫多證券交易所股票代碼:NUMIF)通過開發和提供創新的精神衞生保健以及獲得安全、循證的迷幻輔助療法,幫助人們康復和康復。努米納斯模式-包括迷幻生產、研究和臨牀護理-處於旨在治癒而不是管理抑鬱症、焦慮、創傷、疼痛和藥物使用症狀的轉型的前沿。在努米納斯,我們正在領導將迷幻輔助療法整合到主流臨牀實踐中,併為更健康的社會奠定基礎。

Learn more at and follow us on LinkedIn, Facebook, Twitter, and Instagram.

在LinkedIn、Facebook、Twitter和Instagram上了解更多信息並關注我們。

Forward-looking statements
This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs regarding future performance are "forward-looking statements". Forward-looking statements can be identified by the use of words such as "expects", "does not expect", "is expected", "believes", "intends", "anticipates", "does not anticipate", "believes" or variations of these words, expressions or statements, that certain actions, events or results "may", "could", "would", "might" or "will be" taken, will occur or will be realized. Such forward-looking statements involve risks, uncertainties and other known and unknown factors that could cause actual results, events or developments to differ materially from the results, events or developments expected and expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, dependence on obtaining and maintaining regulatory approvals, including the acquisition and renewal of federal, provincial, municipal, local or other licenses, and any inability to obtain all necessary government authorizations, licenses and permits to operate and expand the Company's facilities; regulatory or policy changes such as changes in applicable laws and regulations, including federal and provincial legalization, due to fluctuations in public opinion, industry perception of integrative mental health, including the use of psychedelic-assisted therapy, delays or inefficiencies or any other reason; any other factor or development likely to hamper the growth of the market; the Company's limited operating and profitability track record; dependence on management; the Company's need for additional financing and the effects of financial market conditions and other factors on the availability of capital; competition, including that of more established and better funded competitors; the continued impact of the COVID-19 pandemic; and the need to build and maintain alliances and partnerships, including with research and development companies, customers and suppliers. These factors should be carefully considered, and readers are cautioned not to place undue reliance on forward-looking statements. Despite the Company's efforts to identify the main risk factors that could cause actual measures, events or results to differ materially from those described in forward-looking statements, other risk factors may cause measures, events or developments to materially differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company does not undertake to revise forward-looking statements, even if new information becomes available as a result of future events, new facts or any other reason, except as required by applicable laws.

前瞻性陳述
本新聞稿包含符合適用證券法的前瞻性陳述。所有非歷史事實的陳述,包括但不限於有關未來估計、計劃、計劃、預測、預測、目標、假設、期望或對未來表現的看法的陳述,都是“前瞻性陳述”。前瞻性陳述可以通過使用諸如“預期”、“不預期”、“預計”、“相信”、“打算”、“預期”、“不預期”、“相信”或這些詞語、表述或陳述的變體來識別,即某些行動、事件或結果“可能”、“可能”、“將”、“可能”或“將會”採取、將會發生或將會實現。此類前瞻性表述涉及風險、不確定因素以及其他已知和未知因素,可能導致實際結果、事件或發展與此類前瞻性表述中明示或暗示的預期結果、事件或發展大相徑庭。這些風險和不確定性包括,但不限於,對獲得和維持監管批准的依賴,包括聯邦、省、市、地方或其他許可證的獲取和續簽,以及無法獲得運營和擴大公司設施的所有必要的政府授權、許可證和許可;監管或政策變化,如由於輿論波動、行業對綜合心理健康的看法,包括使用迷幻輔助治療,適用法律和法規的變化,包括聯邦和省級合法化。, 這些不確定性因素包括:公司運營延遲或效率低下或任何其他原因;可能阻礙市場增長的任何其他因素或發展;公司有限的運營和盈利記錄;對管理層的依賴;公司需要更多融資以及金融市場狀況和其他因素對資本可用性的影響;競爭,包括更成熟、資金更雄厚的競爭對手的競爭;新冠肺炎疫情的持續影響;以及建立和維護聯盟和合作夥伴關係,包括與研發公司、客户和供應商建立和維持聯盟與合作伙伴關係的需要。這些因素應該仔細考慮,提醒讀者不要過度依賴前瞻性陳述。儘管公司努力確定可能導致實際措施、事件或結果與前瞻性陳述中描述的措施、事件或結果大不相同的主要風險因素,但其他風險因素可能會導致措施、事件或發展與預期、估計或打算的措施、事件或發展大不相同。不能保證前瞻性陳述將被證明是準確的,因為實際結果和未來事件可能與前瞻性陳述中預期的大不相同。除非適用法律要求,否則即使由於未來事件、新事實或任何其他原因而獲得新信息,公司也不承諾修改前瞻性陳述。

SOURCE Numinus Wellness Inc.

來源:努米納斯健康公司

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論